Seller record · Telehealth service

Rylo Health

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 1 of 8 criteria. S5, analytical documentation: The tirzepatide page says every batch goes through chemistry and microbiology labs, and no certificate of analysis or lot document is published.

At a glance

Rylo HealthTelehealth service

7/8criteria passed

Price: Semaglutide $139 a month, tirzepatide $229
Sells: compounded tirzepatide, compounded semaglutide, NAD+ injection, and 3 more
FDA letters: None on file

Visit Rylo Health See all eight dispositions

Telehealth service. Passes 7 of 8 criteria. Recorded against Standard v1.1.

A telehealth service selling compounded tirzepatide, semaglutide, NAD+, sermorelin and glutathione injections and a GHK-Cu cream, with monthly and quarterly prices on each page. Care is provided by a named Texas medical group, and the filling pharmacy is named with its address.

Operating entity Rylo Health LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Rylo Health's tirzepatide page; Rylo Health's website
S2	Prescription gating	PASS	Rylo Health's GLP-1 intake page on its start site
S3	Pharmacy identification	PASS	Rylo Health's website
S4	Compounding disclosure	PASS	Rylo Health's tirzepatide page
S5	Analytical documentation	FAIL	Rylo Health's tirzepatide page
S6	Business address	PASS	Rylo Health's terms; Rylo Health's privacy page
S7	Price disclosure	PASS	Rylo Health's semaglutide page; Rylo Health's tirzepatide page; Rylo Health's website
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA US-licensed physician reviews and approves every prescription before it ships, and clinical care is provided by Lone Star Virtual Health PLLC.Source: Rylo Health's tirzepatide page; Rylo Health's website.

S2PASSThe qualify button opens an intake whose first screen asks the buyer's goal weight, and the home page says nothing is paid to start.Source: Rylo Health's GLP-1 intake page on its start site.

S3PASSPrescriptions are filled by VialsRX, 6220 Westpark Dr, Houston, TX 77057, printed with its telephone number.Source: Rylo Health's website.

S4PASSEach drug page states that the compounded drug is not FDA-approved and that FDA does not evaluate compounded drugs for safety, effectiveness or quality.Source: Rylo Health's tirzepatide page.

S5FAILThe tirzepatide page says every batch goes through chemistry and microbiology labs, and no certificate of analysis or lot document is published.Source: Rylo Health's tirzepatide page.

S6PASSRylo Health LLC at 1708 Spring Green Blvd Ste 120 #173, Katy, TX 77494, printed in the terms and the privacy policy.Source: Rylo Health's terms; Rylo Health's privacy page.

S7PASSCompounded semaglutide at $139 a month with no contract, or $100 a month billed $299 quarterly; compounded tirzepatide at $229 a month, or $160 billed $479 quarterly. The NAD+ injection at $219 a month or $549 quarterly, sermorelin at $249 a month or $549 quarterly, glutathione at $399 quarterly and GHK-Cu cream at $499 quarterly.Source: Rylo Health's semaglutide page; Rylo Health's tirzepatide page; Rylo Health's website.

S8PASSNo FDA warning letter names Rylo Health or Rylo Health LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded tirzepatide, compounded semaglutide, NAD+ injection, sermorelin, glutathione injection, GHK-Cu cream.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells NAD+Who sells glutathione Who sells GHK-Cu

Unpaid link. Rylo Health does not pay the site, and nothing is earned when it is used. Funding.

Visit Rylo Health

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.